FDA inspection
MedImmune U.K. Limited: FDA inspection ending Feb 17, 2017
FDA inspection 1007257 · No Action Indicated (NAI) · Liverpool
Key facts
| Inspection ID | 1007257 |
|---|---|
| Firm | MedImmune U.K. Limited |
| FEI number | 3004066112 |
| Address | Plot, 6 Renaissance Way |
| City | Liverpool |
| Country | United Kingdom |
| Fiscal year | 2017 |
| Inspection end date | Feb 17, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data